Head of Oncology Integrated Bioanalysis
AstraZeneca
Waltham, Massachusetts
Lakshmi Amaravadi, is the Head of Oncology Bioanalytical Strategy Function at Astra Zeneca. She oversees development and implementation of PK, PD biomarkers, and Immunogenicity strategies to support preclinical & clinical programs across multiple modalities. Lakshmi has >30 years of industry experience in drug development across multiple therapeutic areas including Oncology, Neurology, autoimmune, metabolic, and rare diseases. During her tenure at Biogen, Sanofi, Shire, and Boston Pharma she contributed successfully to >45 INDs and >12 BLA/NDAs & registrations. Lakshmi is an internationally recognized expert in the translational biomarkers and bioanalytics (PK and immunogenicity), authored multiple white papers, collaborated with industry and regulatory leaders in developing best practices in this area. She served as an elected member of the AAPS Board and is an active leader of AAPS Bioanalytical and Biomarker scientific communities. She is passionate about developing innovative translational approaches to Drug Development, mentoring next generation of scientists. She earned her Ph.D. in Cell, Molecular and Developmental Biology from Indiana State University & fellowship at Walther Oncology Center, Indianapolis.
Disclosure information not submitted.
Hot Topic: 2025 FDA Guidance BMV for Biomarkers: Impact and Path Forward
Tuesday, November 11, 2025
10:30 AM - 11:30 AM CT